ǂa ǂcomprehensive review
David Vogrinc (Author), Katja Goričar (Author), Vita Dolžan (Author)

Abstract

Alzheimer's disease (AD) is a complex neurodegenerative disease, affecting a significant part of the population. The majority of AD cases occur in the elderly with a typical age of onset of the disease above 65 years. AD presents a major burden for the healthcare system and since population is rapidly aging, the burden of the disease will increase in the future. However, no effective drug treatment for a full-blown disease has been developed to date. The genetic background of AD is extensively studied; numerous genome-wide association studies (GWAS) identified significant genes associated with increased risk of AD development. This review summarizes more than 100 risk loci. Many of them may serve as biomarkers of AD progression, even in the preclinical stage of the disease. Furthermore, we used GWAS data to identify key pathways of AD pathogenesis: cellular processes, metabolic processes, biological regulation, localization, transport, regulation of cellular processes, and neurological system processes. Gene clustering into molecular pathways can provide background for identification of novel molecular targets and may support the development of tailored and personalized treatment of AD.

Keywords

Alzheimer's disease;genetic risk factors;pathogenesis;

Data

Language: English
Year of publishing:
Typology: 1.02 - Review Article
Organization: UL MF - Faculty of Medicine
UDC: 616.8
COBISS: 57793283 Link will open in a new window
ISSN: 1663-4365
Views: 15
Downloads: 3
Average score: 0 (0 votes)
Metadata: JSON JSON-RDF JSON-LD TURTLE N-TRIPLES XML RDFA MICRODATA DC-XML DC-RDF RDF

Other data

Secondary language: Slovenian
Secondary keywords: Alzheimerjeva bolezen;genetski dejavniki tveganja;patigeneza;
Type (COBISS): Article
Pages: str. 1-30
Issue: Vol. 13
Chronology: Mar. 2021
DOI: 10.3389/fnagi.2021.646901
ID: 18187512